Suchergebnisse - "Hlupeni, Admire"

PubPharm (14)

1

Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa : an economic analysis of the AMBITION-cm trial

enthalten in: The Lancet. Global health | 2022

von Lawrence, D. | Muthoga, C. | Meya, D. | +133

CommentIn: Lancet Glob Health. 2022 Dec;10(12):e1688. - PMID 36400070

2

Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease

enthalten in: Microbiology spectrum | 2022

von Boyd, K. | Kouamou, V. | Hlupeni, A. | +4

3

Investigating Attitudes, Motivations and Key Influencers for vaccine uptake among late adopters of COVID-19 vaccination in Africa

enthalten in: bioRxiv.org | 2022

von Makadzange, A. | Lau, C. | Dietrich, J. | +8

4

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis

enthalten in: The New England journal of medicine | 2022

von Jarvis, J. | Lawrence, D. | Meya, D. | +140

CommentIn: N Engl J Med. 2022 Mar 24;386(12):1179-1181. - PMID 35320648

5

Survival following screening and preemptive antifungal therapy for subclinical cryptococcal disease in advanced HIV infection

enthalten in: AIDS (London, England) | 2021

von Makadzange, T. | Hlupeni, A. | Machekano, R. | +8

6

Adverse outcomes after partner bereavement in people with reduced kidney function : Parallel cohort studies in England and Denmark

enthalten in: PloS one | 2021

von Bidulka, P. | Vestergaard, S. | Hlupeni, A. | +7

7

AMBIsome Therapy Induction OptimisatioN (AMBITION) : High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study

enthalten in: BMJ open | 2019

von Ponatshego, P. | Lawrence, D. | Youssouf, N. | +35

8

Correction to : AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

enthalten in: Trials | 2019

von Lawrence, D. | Youssouf, N. | Molloy, S. | +26

ErratumFor: Trials. 2018 Nov 23;19(1):649. - PMID 30470259

9

Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

enthalten in: Trials | 2019

von Lawrence, D. | Youssouf, N. | Molloy, S. | +26

10

Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

enthalten in: Trials | 2019

von Lawrence, D. | Youssouf, N. | Molloy, S. | +26